PLX51107
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PLX51107, covering 2025-01-28 to 2025-01-28. Get the full timeline:
Most recent: Clinical Trial Update: Novel BET Inhibitor PLX51107 for Steroid-Refractory Acute GVHD [Phase 1, Phase 2]